Improving Treatment Outcomes through Danny Analytics

Sofia, May 15, 2018 – Sqilline officially launched its newest application Danny Analytics for analyzing and evaluating massive amounts of real-world data from oncology and cardiology fields. Danny Analytics enables physicians, pharmaceutical companies and payers to gain insight into real-world evidence of patient care, particularly in this era of value-based care.

Powered by SAP HANA DB, our solution taps into the capabilities of rapid in-memory data processing and computation for improving healthcare Danny Analytics provides real-time aggregated analyses of structured and unstructured health data with integration of registries, external clinical and drug databases, etc. It utilizes proprietary algorithms and methodologies for data quality, data validation and predictive insights based on de-identified patient records.

By harnessing the power of modern technology, the solution is an advanced tool for: 

  • Quick and understandable visualization of clinical data from health records, hospital information systems, and other registries
  • Analyses on how specific factors influence patient survival and comparison of the effectiveness of different treatment options
  • Accumulation of large systemized analytical datasets – Big Data
  • Large cohorts of patients are compared and analyzed within seconds
  • Data security and patient privacy

For pharmaceutical companies, Danny Analytics can provide real-world evidence to update drug labels, drug effectiveness, market access and adjust drug production in oncology and cardiology.

For government health institutions (payers), Danny Analytics can support the process of transforming healthcare based on therapeutic approach, effectiveness, and safety, which in turn deliver high-quality, cost-effective care to all.

Danny Analytics is already uploaded with data from several leading Oncology hospitals in Bulgaria and has accumulated powerful data reports in specific diseases for physicians and researchers.

Sqilline is a leading SAP Partner in Europe in the areas of Precision Medicine, Life Science and Healthcare. Our team has built the 1st Analytics Healthcare platform for real-world data for the two of the largest health areas – Oncology and Cardiology in Central and Eastern Europe.

Presenting on stage is Sqilline’s Managing Director – Ms. Desislava Mihaylova
Presenting on stage is Sqilline’s Senior Data Scientist – Mr. Boyang Zhao, PhD
Special guests at the launch (from left to right) – Dr. Borislav Borisov, Prof. Dr. Galina Kurteva and Prof. Dr. Ivo Petrov
Share this article:

More News & Highlights

News

A RWE Comparison of Breast Cancer Targeted Therapy with RCTs Using Danny Platform

Biotechnology & Biotechnological Equipment, a fully open access research journal, has published the Research Article regarding the real-world effectiveness and outcomes of targeted therapy in patients with...

Read more...

News

Sqilline Partners with Dăruiește Aripi Association and Romanian Society of Pediatric Oncology and Hematology

Transforming Pediatric Oncology Across All Regions of Romania Announced Today Bucharest, October 16, 2023 – In a significant step toward improving the survival rates of...

Read more...

News

Sqilline and Fundeni Clinical Institute unite through a strategic partnership for access to high-quality Real-World Data

Sqilline is proud to announce its partnership with The Fundeni Clinical Institute in Romania. The focus of this partnership is the deployment of the analytic...

Read more...